Last update 01 Nov 2024
Alcon (China) Ophthalmic Product Co. Ltd.
Last update 01 Nov 2024
Overview
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
0.2%盐酸奥洛他定滴眼液每日1次与0.1%盐酸奥洛他定滴眼液每日2次治疗中国过敏性结膜炎受试者的对比研究
[Translation] A comparative study of 0.2% olopatadine hydrochloride eye drops once daily and 0.1% olopatadine hydrochloride eye drops twice daily in the treatment of allergic conjunctivitis in Chinese subjects
在中国人群中评估0.5%莫西沙星滴眼液和0.3%氧氟沙星滴眼液治疗细菌性结膜炎的安全性与疗效
[Translation] Evaluation of the safety and efficacy of 0.5% moxifloxacin eye drops and 0.3% ofloxacin eye drops in the treatment of bacterial conjunctivitis in the Chinese population
100 Clinical Results associated with Alcon (China) Ophthalmic Product Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Alcon (China) Ophthalmic Product Co. Ltd.
Login to view more data
100 Translational Medicine associated with Alcon (China) Ophthalmic Product Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 07 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free